title: Agranulocytosis and fever seven weeks after starting abacavir.
authors.forename: S U
authors.initials: SU
authors.lastname: Sankatsing
authors.forename: J M
authors.initials: JM
authors.lastname: Prins
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D015224:Dideoxynucleosides / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology; D004359:Drug Therapy, Combination; D005334:Fever / Q000139:chemically induced*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir